Reports

Ideas That Generate Results

Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023

Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : May, 2017| No. of Pages : 100

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 2500.00
CD-ROM Mail Delivery
US$ 2700.00
Hard Copy Mail Delivery
US$ 2700.00
Electronic Access - Multi-User License
US$ 3500.00
1. Analyst View
 
2. Research Methodology
 
3. Endometrial Cancer - Epidemiology & Risk Factors
 
4. Endometrial Cancer Therapeutics - An Introduction
 
5. Market Dynamics
    5.1 Drivers
          5.1.1 Rising Global Endometrial Cancer Epidemics
          5.1.2 Obesity Fuelling Endometrial Cancer Incidences
          5.1.3 Increasing Healthcare Expenditure
    5.2 Challenges
          5.2.1 High Cost Associated with the Treatment
          5.2.2 Increasing Stringency in Regulatory Requirements
 
6. Endometrial Cancer Therapeutics Market Outlook to 2023
    6.1 Market Potential
 
7. Market Segmentation
    7.1 By Therapy
          7.1.1 Chemotherapy
          7.1.2 Hormonal Therapy
          7.1.3 Radiation Therapy
          7.1.4 Surgery
    7.2 By End Users
          7.2.1 Research Institutes & CROs
          7.2.2 Hospitals & Clinics
    7.3 By Geography
          7.3.1 North America
          7.3.2 Europe
          7.3.3 Asia Pacific
          7.3.4 Rest of the World
 
8. Endometrial Cancer Therapeutic Drugs Pipeline Analysis
    8.1 By Industry
          8.1.1 By Clinical Phase
    8.2 By Research Collaborations
          8.2.1 By Clinical Phase
 
9. Trends and Developments
    9.1 Womb Lining Models for further Endometriosis Investigation
    9.2 Whole Exome Sequencing Aiding Identification of Targeted Therapies
    9.3 Sentinel Lymph-node Mapping: Less Invasive Method for Staging
    9.4 Metformin Holds Promise for Treating Endometrial Cancer
    9.5 Adjuvant Chemotherapy Feasible for High Risk Endometrial Cancer
 
10. Strategic Mergers & Collaborations in the Endometrial Cancer Therapeutics Industry
 
11. Competitive Assessment
      11.1 Bayer AG
      11.2 F. Hoffman La Roche Ltd.
      11.3 Bristol-Myers Squibb Company
      11.4 Merck KGaA
      11.5 Novartis AG
      11.6 Takeda Pharmaceutical Company Limited
      11.7 Eli Lilly and Company
      11.8 Sanofi
      11.9 GlaxoSmithKline plc
      11.10 ArQule, Inc.
Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.